Fig. 8From: A bioanalytical UHPLC based method used for the quantification of Thymoquinone-loaded-PLGA-nanoparticles in the treatment of epilepsyPharmacokinetic Profile of Thymoquinone (THQ) concentration in brain at different time intervals after administration of developed THQ-loaded-PLGA-NPs compared with pure THQ. Significance was determined as ***p < 0.001, **p < 0.01, *p < 0.05, when compared with pure THQ (IV) solutionBack to article page